These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21646684)

  • 1. Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells.
    Acquati F; Monti L; Lualdi M; Fabbri M; Sacco MG; Gribaldo L; Taramelli R
    Oncotarget; 2011 Jun; 2(6):477-84. PubMed ID: 21646684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor and metastasis suppression by the human RNASET2 gene.
    Acquati F; Possati L; Ferrante L; Campomenosi P; Talevi S; Bardelli S; Margiotta C; Russo A; Bortoletto E; Rocchetti R; Calza R; Cinquetti R; Monti L; Salis S; Barbanti-Brodano G; Taramelli R
    Int J Oncol; 2005 May; 26(5):1159-68. PubMed ID: 15809705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNASET2 silencing affects miRNAs and target gene expression pattern in a human ovarian cancer cell model.
    Turconi G; Scaldaferri D; Fabbri M; Monti L; Lualdi M; Pedrini E; Gribaldo L; Taramelli R; Acquati F
    Int J Oncol; 2016 Dec; 49(6):2637-2646. PubMed ID: 27840914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.
    Acquati F; Bertilaccio S; Grimaldi A; Monti L; Cinquetti R; Bonetti P; Lualdi M; Vidalino L; Fabbri M; Sacco MG; van Rooijen N; Campomenosi P; Vigetti D; Passi A; Riva C; Capella C; Sanvito F; Doglioni C; Gribaldo L; Macchi P; Sica A; Noonan DM; Ghia P; Taramelli R
    Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1104-9. PubMed ID: 21189302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNASET2 as a tumor antagonizing gene in a melanoma cancer model.
    Monti L; Rodolfo M; Lo Russo G; Noonan D; Acquati F; Taramelli R
    Oncol Res; 2008; 17(2):69-74. PubMed ID: 18543608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase.
    Lualdi M; Pedrini E; Rea K; Monti L; Scaldaferri D; Gariboldi M; Camporeale A; Ghia P; Monti E; Tomassetti A; Acquati F; Taramelli R
    Oncotarget; 2015 Apr; 6(10):7851-65. PubMed ID: 25797262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of tumor suppressor gene ribonuclease T2 and gametogenetin binding protein 2 is associated with drug resistance in ovarian cancer.
    Yin F; Liu L; Liu X; Li G; Zheng L; Li D; Wang Q; Zhang W; Li L
    Oncol Rep; 2014 Jul; 32(1):362-72. PubMed ID: 24842157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.
    Dafou D; Grun B; Sinclair J; Lawrenson K; Benjamin EC; Hogdall E; Kruger-Kjaer S; Christensen L; Sowter HM; Al-Attar A; Edmondson R; Darby S; Berchuck A; Laird PW; Pearce CL; Ramus SJ; Jacobs IJ; Gayther SA
    Neoplasia; 2010 Jul; 12(7):579-89. PubMed ID: 20651987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis.
    Bruno A; Noonan DM; Valli R; Porta G; Taramelli R; Mortara L; Acquati F
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival.
    Barton CA; Gloss BS; Qu W; Statham AL; Hacker NF; Sutherland RL; Clark SJ; O'Brien PM
    Br J Cancer; 2010 Jan; 102(1):87-96. PubMed ID: 19935792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis.
    Acquati F; Lualdi M; Bertilaccio S; Monti L; Turconi G; Fabbri M; Grimaldi A; Anselmo A; Inforzato A; Collotta A; Cimetti L; Riva C; Gribaldo L; Ghia P; Taramelli R
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8140-5. PubMed ID: 23630276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27.
    Acquati F; Morelli C; Cinquetti R; Bianchi MG; Porrini D; Varesco L; Gismondi V; Rocchetti R; Talevi S; Possati L; Magnanini C; Tibiletti MG; Bernasconi B; Daidone MG; Shridhar V; Smith DI; Negrini M; Barbanti-Brodano G; Taramelli R
    Oncogene; 2001 Feb; 20(8):980-8. PubMed ID: 11314033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.
    Wiechen K; Diatchenko L; Agoulnik A; Scharff KM; Schober H; Arlt K; Zhumabayeva B; Siebert PD; Dietel M; Schäfer R; Sers C
    Am J Pathol; 2001 Nov; 159(5):1635-43. PubMed ID: 11696424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into hypoxia-related mechanisms involved in different microvascular patterns of bronchopulmonary carcinoids and poorly differentiated neuroendocrine carcinomas. Role of ribonuclease T2 (RNASET2) and HIF-1α.
    Uccella S; La Rosa S; Scaldaferri D; Monti L; Maragliano R; Sorrenti E; Gariboldi M; Taramelli R; Sessa F; Acquati F
    Hum Pathol; 2018 Sep; 79():66-76. PubMed ID: 29763721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Strategies for Expression and Purification of Recombinant Human RNASET2 Protein in Pichia pastoris.
    Lualdi M; Pedrini E; Petroni F; Näsman J; Lindqvist C; Scaldaferri D; Taramelli R; Inforzato A; Acquati F
    Mol Biotechnol; 2015 Jun; 57(6):513-25. PubMed ID: 25663099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNASET2--an autoantigen in anaplastic large cell lymphoma identified by protein array analysis.
    Patel S; Chen H; Monti L; Gould E; Haralambieva E; Schmid J; Toomey D; Woessmann W; Roncador G; Hatton CS; Liggins AP; Taramelli R; Banham AH; Acquati F; Murphy D; Pulford K
    J Proteomics; 2012 Sep; 75(17):5279-92. PubMed ID: 22732457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.
    Sers C; Husmann K; Nazarenko I; Reich S; Wiechen K; Zhumabayeva B; Adhikari P; Schröder K; Gontarewicz A; Schäfer R
    Oncogene; 2002 Apr; 21(18):2829-39. PubMed ID: 11973642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of large-scale characteristic genes of Müllerian inhibiting substance in human ovarian cancer cells.
    Nam SW; Jo YS; Eun JW; Song JY; Ryu KS; Lee JY; Lee JM; Maclaughlin DT; Kim JH
    Int J Mol Med; 2009 May; 23(5):589-96. PubMed ID: 19360316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
    Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
    Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.